Quick Answer
CONMED Corp reported Cash and Equivalents of $25.86 million for fiscal year 2019.
CONMED Corp Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2019 | $25.86M | +47.7% |
| 2018 | $17.51M | -46.3% |
| 2017 | $32.62M | +18.9% |
| 2016 | $27.43M | -62.2% |
| 2015 | $72.50M | +9.3% |
| 2014 | $66.33M | +21.8% |
| 2013 | $54.44M | +129.5% |
| 2012 | $23.72M | -8.9% |
| 2011 | $26.05M | +109.8% |
| 2010 | $12.42M | +23.0% |
| 2009 | $10.10M | -14.5% |
| 2008 | $11.81M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2019 | $30.07M | +1.3% | +33.3% |
| June 30, 2019 | $22.55M | -3.6% | -3.7% |
| March 31, 2019 | $23.41M | +10.8% | +33.7% |
| December 31, 2018 | $17.51M | -46.3% | -41.0% |
| September 30, 2018 | $29.69M | -32.6% | +26.9% |
| June 30, 2018 | $23.40M | -41.7% | +10.7% |
| March 31, 2018 | $21.13M | -39.0% | -35.2% |
| December 31, 2017 | $32.62M | +18.9% | -25.9% |
- CONMED Corp showed an increase of +47.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2019 period, CONMED Corp’s cash and equivalents has grown by 118.9% (from $11.81 million to $25.86 million).
- The most recent figure is from CONMED Corp’s fiscal year 2019 report (Form 10-K), filed with the SEC on February 24, 2020.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: